From Dermatology Times The U.S. landscape of neuromodulators, which play well with other aesthetic treatments, continues to expand, report experts at this year's Cosmetic Bootcamp.
From Dermatology Times FDA-approved Qbrexza (glycopyrronium), a topical treatment for primary axillary hyperhidrosis, is expected to be available by prescription in October 2018.
From Dermatology Times The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, according to the Office of Cosmetics and Color for the FDA.
Have comments or questions about the eNewsletter? Contact us!
The Aesthetic Channel editor Eliza Cabana at [email protected]
The Aesthetic Guide editor Erin Velardo at [email protected]
Channel Director Heather Onorati at [email protected]
ADVERTISEMENT
There's no such thing as an "ideal" practice anymore.
Think body contouring doesn't make sense for your practice? In this podcast, Dr. Sandra Johnson discusses how implementing innovative technologies can help any practice thrive, regardless of setting. Listen to this podcast to learn more.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%